Proteinuria and hypertension with tyrosine kinase inhibitors

Praveen Kandula, Rajiv Agarwal

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Tyrosine kinases are important for the development of pathological angiogenesis, a critical factor for survival and proliferation of tumor cells. Inhibition of tyrosine kinases either through targeted binding of its ligands or inhibition of its receptor has led to significant hindrance in angiogenesis and has improved survival for several cancers. Several of these antibodies or small molecules have been approved for treatment of recurrent and resistant cancers over the last decade. Although generally well tolerated, tyrosine kinase inhibitors have been linked with development of hypertension and proteinuria. We review the literature for incidence and severity of hypertension and proteinuria among several tyrosine kinase inhibitors, their pathophysiologic mechanisms, and provide a guide for screening and management.

Original languageEnglish
Pages (from-to)1271-1277
Number of pages7
JournalKidney International
Volume80
Issue number12
DOIs
StatePublished - Dec 2 2011

Fingerprint

Proteinuria
Protein-Tyrosine Kinases
Hypertension
Pathologic Neovascularization
Neoplasms
Cell Proliferation
Ligands
Antibodies
Incidence

Keywords

  • bevacizumab
  • hypertension
  • proteinuria
  • tyrosine kinase inhibitors

ASJC Scopus subject areas

  • Nephrology

Cite this

Proteinuria and hypertension with tyrosine kinase inhibitors. / Kandula, Praveen; Agarwal, Rajiv.

In: Kidney International, Vol. 80, No. 12, 02.12.2011, p. 1271-1277.

Research output: Contribution to journalArticle

Kandula, Praveen ; Agarwal, Rajiv. / Proteinuria and hypertension with tyrosine kinase inhibitors. In: Kidney International. 2011 ; Vol. 80, No. 12. pp. 1271-1277.
@article{b14d3ce840034b078046767c95a99614,
title = "Proteinuria and hypertension with tyrosine kinase inhibitors",
abstract = "Tyrosine kinases are important for the development of pathological angiogenesis, a critical factor for survival and proliferation of tumor cells. Inhibition of tyrosine kinases either through targeted binding of its ligands or inhibition of its receptor has led to significant hindrance in angiogenesis and has improved survival for several cancers. Several of these antibodies or small molecules have been approved for treatment of recurrent and resistant cancers over the last decade. Although generally well tolerated, tyrosine kinase inhibitors have been linked with development of hypertension and proteinuria. We review the literature for incidence and severity of hypertension and proteinuria among several tyrosine kinase inhibitors, their pathophysiologic mechanisms, and provide a guide for screening and management.",
keywords = "bevacizumab, hypertension, proteinuria, tyrosine kinase inhibitors",
author = "Praveen Kandula and Rajiv Agarwal",
year = "2011",
month = "12",
day = "2",
doi = "10.1038/ki.2011.288",
language = "English",
volume = "80",
pages = "1271--1277",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Proteinuria and hypertension with tyrosine kinase inhibitors

AU - Kandula, Praveen

AU - Agarwal, Rajiv

PY - 2011/12/2

Y1 - 2011/12/2

N2 - Tyrosine kinases are important for the development of pathological angiogenesis, a critical factor for survival and proliferation of tumor cells. Inhibition of tyrosine kinases either through targeted binding of its ligands or inhibition of its receptor has led to significant hindrance in angiogenesis and has improved survival for several cancers. Several of these antibodies or small molecules have been approved for treatment of recurrent and resistant cancers over the last decade. Although generally well tolerated, tyrosine kinase inhibitors have been linked with development of hypertension and proteinuria. We review the literature for incidence and severity of hypertension and proteinuria among several tyrosine kinase inhibitors, their pathophysiologic mechanisms, and provide a guide for screening and management.

AB - Tyrosine kinases are important for the development of pathological angiogenesis, a critical factor for survival and proliferation of tumor cells. Inhibition of tyrosine kinases either through targeted binding of its ligands or inhibition of its receptor has led to significant hindrance in angiogenesis and has improved survival for several cancers. Several of these antibodies or small molecules have been approved for treatment of recurrent and resistant cancers over the last decade. Although generally well tolerated, tyrosine kinase inhibitors have been linked with development of hypertension and proteinuria. We review the literature for incidence and severity of hypertension and proteinuria among several tyrosine kinase inhibitors, their pathophysiologic mechanisms, and provide a guide for screening and management.

KW - bevacizumab

KW - hypertension

KW - proteinuria

KW - tyrosine kinase inhibitors

UR - http://www.scopus.com/inward/record.url?scp=82455210240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455210240&partnerID=8YFLogxK

U2 - 10.1038/ki.2011.288

DO - 10.1038/ki.2011.288

M3 - Article

VL - 80

SP - 1271

EP - 1277

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 12

ER -